{"transactions":[{"id":1863670,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":112616,"kind":"person","name":"Sablich Kim","position":1,"cik":"0001758790","reported_name":"Sablich Kim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GM of U.S."}}],"security":"Ordinary Shares","published_at":"2023-06-07T23:15:12.000Z","date":"2023-06-05","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2082,"price":129.73,"value":270097.86,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units."}],"balance_after":28478,"source":{"system":"sec-edgar","filing":"0001765581-23-000046","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558123000046/edgardoc.xml","form_type":"4"}},{"id":1958568,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":112616,"kind":"person","name":"Sablich Kim","position":1,"cik":"0001758790","reported_name":"Sablich Kim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GM of U.S., Commercial Ma"}}],"security":"Ordinary Shares","published_at":"2023-03-10T23:10:38.000Z","date":"2023-03-08","kind":"sale","acquired":false,"shares":1261,"price":140.19,"value":176779.59,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects the sale of ordinary shares executed in multiple transactions at prices ranging from $139.97 to $140.30. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."}],"balance_after":30560,"source":{"system":"sec-edgar","filing":"0001765581-23-000036","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558123000036/edgardoc.xml","form_type":"4"}},{"id":1958567,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":112616,"kind":"person","name":"Sablich Kim","position":1,"cik":"0001758790","reported_name":"Sablich Kim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GM of U.S., Commercial Ma"}}],"security":"Ordinary Shares","published_at":"2023-03-10T23:10:38.000Z","date":"2023-03-08","kind":"sale","acquired":false,"shares":1752,"price":139.42,"value":244263.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the sale of ordinary shares executed in multiple transactions at prices ranging from $138.95 to $139.94. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."}],"balance_after":31821,"source":{"system":"sec-edgar","filing":"0001765581-23-000036","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558123000036/edgardoc.xml","form_type":"4"}},{"id":1965448,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":112616,"kind":"person","name":"Sablich Kim","position":1,"cik":"0001758790","reported_name":"Sablich Kim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GM of U.S., Commercial Ma"}}],"security":"Ordinary Shares","published_at":"2023-03-08T01:50:13.000Z","date":"2023-03-05","kind":"tax_withholding","acquired":false,"shares":1610,"price":142.78,"value":229875.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units."}],"balance_after":33573,"source":{"system":"sec-edgar","filing":"0001765581-23-000017","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558123000017/edgardoc.xml","form_type":"4"}},{"id":1965447,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":112616,"kind":"person","name":"Sablich Kim","position":1,"cik":"0001758790","reported_name":"Sablich Kim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GM of U.S., Commercial Ma"}}],"security":"Ordinary Shares","published_at":"2023-03-08T01:50:13.000Z","date":"2023-03-03","kind":"grant","acquired":true,"shares":10429,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of March 5, 2023, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years."}],"balance_after":35183,"source":{"system":"sec-edgar","filing":"0001765581-23-000017","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558123000017/edgardoc.xml","form_type":"4"}},{"id":1972643,"issuer":{"id":16554,"kind":"organization","name":"Eiger BioPharmaceuticals, Inc.","symbol":"EIGR"},"owners":[{"id":112616,"kind":"person","name":"Sablich Kim","position":1,"cik":"0001758790","reported_name":"Sablich Kim","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-03T20:50:03.000Z","date":"2023-03-01","kind":"grant","acquired":true,"shares":28000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in equal monthly installments over 12 months measured from March 1, 2023, subject to Reporting Person's continuous service status as of each such date."}],"balance_after":28000,"derivative":{"exercise_price":1.705,"expiration_date":"2033-02-28","underlying":"Common Stock","underlying_shares":28000},"source":{"system":"sec-edgar","filing":"0001140361-23-010160","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1305253/000114036123010160/form4.xml","form_type":"4"}},{"id":2238887,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":112616,"kind":"person","name":"Sablich Kim","position":1,"cik":"0001758790","reported_name":"Sablich Kim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GM, North America"}}],"security":"Ordinary Shares","published_at":"2022-06-08T20:56:42.000Z","date":"2022-06-07","kind":"sale","acquired":false,"shares":101,"price":152.595,"value":15412.095,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $152.595 to $152.60, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein."}],"balance_after":24754,"source":{"system":"sec-edgar","filing":"0001765581-22-000057","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558122000057/edgardoc.xml","form_type":"4"}},{"id":2238886,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":112616,"kind":"person","name":"Sablich Kim","position":1,"cik":"0001758790","reported_name":"Sablich Kim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GM, North America"}}],"security":"Ordinary Shares","published_at":"2022-06-08T20:56:42.000Z","date":"2022-06-07","kind":"sale","acquired":false,"shares":1317,"price":151.8725,"value":200016.0825,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Reflects the sale of ordinary shares executed in multiple transactions at prices ranging from $151.35 to $152.21. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."}],"balance_after":24855,"source":{"system":"sec-edgar","filing":"0001765581-22-000057","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558122000057/edgardoc.xml","form_type":"4"}},{"id":2238885,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":112616,"kind":"person","name":"Sablich Kim","position":1,"cik":"0001758790","reported_name":"Sablich Kim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GM, North America"}}],"security":"Ordinary Shares","published_at":"2022-06-08T20:56:42.000Z","date":"2022-06-07","kind":"sale","acquired":false,"shares":573,"price":150.676,"value":86337.348,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $150.32 to $151.00. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."}],"balance_after":26172,"source":{"system":"sec-edgar","filing":"0001765581-22-000057","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558122000057/edgardoc.xml","form_type":"4"}},{"id":2238884,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":112616,"kind":"person","name":"Sablich Kim","position":1,"cik":"0001758790","reported_name":"Sablich Kim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GM, North America"}}],"security":"Ordinary Shares","published_at":"2022-06-08T20:56:42.000Z","date":"2022-06-07","kind":"sale","acquired":false,"shares":250,"price":149.2249,"value":37306.225,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $149.12 to $149.70. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."}],"balance_after":26745,"source":{"system":"sec-edgar","filing":"0001765581-22-000057","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558122000057/edgardoc.xml","form_type":"4"}},{"id":2238883,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":112616,"kind":"person","name":"Sablich Kim","position":1,"cik":"0001758790","reported_name":"Sablich Kim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GM, North America"}}],"security":"Ordinary Shares","published_at":"2022-06-08T20:56:42.000Z","date":"2022-06-07","kind":"sale","acquired":false,"shares":200,"price":148.209,"value":29641.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $148.05 to $148.36. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."}],"balance_after":26995,"source":{"system":"sec-edgar","filing":"0001765581-22-000057","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558122000057/edgardoc.xml","form_type":"4"}},{"id":2238882,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":112616,"kind":"person","name":"Sablich Kim","position":1,"cik":"0001758790","reported_name":"Sablich Kim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GM, North America"}}],"security":"Ordinary Shares","published_at":"2022-06-08T20:56:42.000Z","date":"2022-06-06","kind":"sale","acquired":false,"shares":1388,"price":152.15,"value":211184.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":27195,"source":{"system":"sec-edgar","filing":"0001765581-22-000057","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558122000057/edgardoc.xml","form_type":"4"}},{"id":2238881,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":112616,"kind":"person","name":"Sablich Kim","position":1,"cik":"0001758790","reported_name":"Sablich Kim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GM, North America"}}],"security":"Ordinary Shares","published_at":"2022-06-08T20:56:42.000Z","date":"2022-06-06","kind":"tax_withholding","acquired":false,"shares":1759,"price":149.25,"value":262530.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units."}],"balance_after":28583,"source":{"system":"sec-edgar","filing":"0001765581-22-000057","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558122000057/edgardoc.xml","form_type":"4"}},{"id":2337396,"issuer":{"id":16554,"kind":"organization","name":"Eiger BioPharmaceuticals, Inc.","symbol":"EIGR"},"owners":[{"id":112616,"kind":"person","name":"Sablich Kim","position":1,"cik":"0001758790","reported_name":"Sablich Kim","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-11T21:06:57.000Z","date":"2022-03-11","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in equal monthly installments over 12 months measured from March 11, 2022 subject to Reporting Person's continuous service status as of each such date."}],"balance_after":12000,"derivative":{"exercise_price":5.1,"expiration_date":"2032-03-10","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001140361-22-009263","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1305253/000114036122009263/form4.xml","form_type":"4"}},{"id":2337395,"issuer":{"id":16554,"kind":"organization","name":"Eiger BioPharmaceuticals, Inc.","symbol":"EIGR"},"owners":[{"id":112616,"kind":"person","name":"Sablich Kim","position":1,"cik":"0001758790","reported_name":"Sablich Kim","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-03-11T21:06:57.000Z","date":"2022-03-11","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying Restricted Stock Units award that will vest on the first anniversary of the grant date of March 11, 2022."}],"balance_after":6000,"source":{"system":"sec-edgar","filing":"0001140361-22-009263","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1305253/000114036122009263/form4.xml","form_type":"4"}},{"id":2341468,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":112616,"kind":"person","name":"Sablich Kim","position":1,"cik":"0001758790","reported_name":"Sablich Kim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GM, North America"}}],"security":"Ordinary Shares","published_at":"2022-03-09T23:05:27.000Z","date":"2022-03-05","kind":"tax_withholding","acquired":false,"shares":746,"price":153.96,"value":114854.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units."}],"balance_after":30342,"source":{"system":"sec-edgar","filing":"0001765581-22-000028","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558122000028/edgardoc.xml","form_type":"4"}},{"id":2341467,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":112616,"kind":"person","name":"Sablich Kim","position":1,"cik":"0001758790","reported_name":"Sablich Kim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GM, North America"}}],"security":"Ordinary Shares","published_at":"2022-03-09T23:05:27.000Z","date":"2022-03-03","kind":"grant","acquired":true,"shares":9953,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of March 5, 2022, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years."}],"balance_after":31088,"source":{"system":"sec-edgar","filing":"0001765581-22-000028","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558122000028/edgardoc.xml","form_type":"4"}},{"id":2512540,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":112616,"kind":"person","name":"Sablich Kim","position":1,"cik":"0001758790","reported_name":"Sablich Kim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GM, North America"}}],"security":"Ordinary Shares","published_at":"2021-11-16T00:30:58.000Z","date":"2021-11-11","kind":"sale","acquired":false,"shares":2748,"price":135.0074,"value":371000.3352,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $135.00 to $135.075, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein."}],"balance_after":21135,"source":{"system":"sec-edgar","filing":"0001765581-21-000125","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558121000125/edgardoc.xml","form_type":"4"}},{"id":2675368,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":112616,"kind":"person","name":"Sablich Kim","position":1,"cik":"0001758790","reported_name":"Sablich Kim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GM, North America"}}],"security":"Ordinary Shares","published_at":"2021-06-09T22:55:23.000Z","date":"2021-06-05","kind":"tax_withholding","acquired":false,"shares":1452,"price":176.47,"value":256234.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units."}],"balance_after":23883,"source":{"system":"sec-edgar","filing":"0001765581-21-000061","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558121000061/edgardoc.xml","form_type":"4"}},{"id":2740716,"issuer":{"id":16554,"kind":"organization","name":"Eiger BioPharmaceuticals, Inc.","symbol":"EIGR"},"owners":[{"id":112616,"kind":"person","name":"Sablich Kim","position":1,"cik":"0001758790","reported_name":"Sablich Kim","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-04-23T17:35:09.000Z","date":"2021-04-23","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in equal monthly installments over 36 months measured from April 23, 2019 subject to Reporting Person's continuous service status as of each such date."}],"balance_after":25000,"derivative":{"exercise_price":8.43,"expiration_date":"2031-04-22","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-21-028175","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1305253/000120919121028175/doc4.xml","form_type":"4"}},{"id":2825855,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":112616,"kind":"person","name":"Sablich Kim","position":1,"cik":"0001758790","reported_name":"Sablich Kim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GM, North America"}}],"security":"Ordinary Shares","published_at":"2021-03-01T23:17:31.000Z","date":"2021-02-25","kind":"grant","acquired":true,"shares":8535,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of March 5, 2021, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years."}],"balance_after":25335,"source":{"system":"sec-edgar","filing":"0001765581-21-000028","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558121000028/edgardoc.xml","form_type":"4"}},{"id":3064581,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":112616,"kind":"person","name":"Sablich Kim","position":1,"cik":"0001758790","reported_name":"Sablich Kim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GM, North America"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-08-07T23:26:18.000Z","date":"2020-08-06","kind":"grant","acquired":true,"shares":38856,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options are granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the vesting commencement date of June 1, 2020, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in 36 equal monthly installments thereafter."}],"balance_after":38856,"derivative":{"exercise_price":127.07,"expiration_date":"2030-08-05","underlying":"Ordinary Shares","underlying_shares":38856},"source":{"system":"sec-edgar","filing":"0001765581-20-000065","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558120000065/edgardoc.xml","form_type":"4"}},{"id":3064580,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":112616,"kind":"person","name":"Sablich Kim","position":1,"cik":"0001758790","reported_name":"Sablich Kim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GM, North America"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2020-08-07T23:26:18.000Z","date":"2020-08-06","kind":"grant","acquired":true,"shares":3144,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options are granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the vesting commencement date of June 1, 2020, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in 36 equal monthly installments thereafter."}],"balance_after":3144,"derivative":{"exercise_price":127.07,"expiration_date":"2030-08-05","underlying":"Ordinary Shares","underlying_shares":3144},"source":{"system":"sec-edgar","filing":"0001765581-20-000065","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558120000065/edgardoc.xml","form_type":"4"}},{"id":3064579,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":112616,"kind":"person","name":"Sablich Kim","position":1,"cik":"0001758790","reported_name":"Sablich Kim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & GM, North America"}}],"security":"Ordinary Shares","published_at":"2020-08-07T23:26:18.000Z","date":"2020-08-06","kind":"grant","acquired":true,"shares":16800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of June 5, 2020, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years."}],"balance_after":16800,"source":{"system":"sec-edgar","filing":"0001765581-20-000065","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558120000065/edgardoc.xml","form_type":"4"}},{"id":3180177,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":112616,"kind":"person","name":"Sablich Kim","position":1,"cik":"0001758790","reported_name":"Sablich Kim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-04-07T17:14:42.000Z","date":"2020-04-03","kind":"grant","acquired":true,"shares":134464,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/4 of the common shares underlying this option vest on April 3, 2021, and 1/16 of the common shares underlying this option vest each quarter thereafter, provided the Reporting Person has provided continuous service to the Issuer or its affiliates on each such date."}],"balance_after":134464,"derivative":{"exercise_price":8.08,"expiration_date":"2030-04-02","underlying":"Common Shares","underlying_shares":134464},"source":{"system":"sec-edgar","filing":"0001209191-20-023796","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1679082/000120919120023796/doc4.xml","form_type":"4"}},{"id":3180176,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":112616,"kind":"person","name":"Sablich Kim","position":1,"cik":"0001758790","reported_name":"Sablich Kim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Shares","published_at":"2020-04-07T17:14:42.000Z","date":"2020-04-03","kind":"grant","acquired":true,"shares":87805,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Common Shares are to be acquired upon the vesting of certain Restricted Stock Units (\"RSUs\") granted to the Reporting Person. 1/4 of the common shares underlying the RSUs vest on April 3, 2021, and 1/16 of the common shares underlying the RSUs vest each quarter thereafter, provided the Reporting Person has provided continuous service to the Issuer or its affiliates on each such date."}],"balance_after":146710,"source":{"system":"sec-edgar","filing":"0001209191-20-023796","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1679082/000120919120023796/doc4.xml","form_type":"4"}},{"id":3200188,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":112616,"kind":"person","name":"Sablich Kim","position":1,"cik":"0001758790","reported_name":"Sablich Kim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2020-03-19T16:32:47.000Z","date":"2020-03-18","kind":"sale","acquired":false,"shares":15,"price":6.93,"value":103.95,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I."}],"balance_after":58905,"source":{"system":"sec-edgar","filing":"0001209191-20-020279","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1679082/000120919120020279/doc4.xml","form_type":"4"}},{"id":3200187,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":112616,"kind":"person","name":"Sablich Kim","position":1,"cik":"0001758790","reported_name":"Sablich Kim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2020-03-19T16:32:47.000Z","date":"2020-03-18","kind":"sale","acquired":false,"shares":770,"price":7.38,"value":5682.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I."}],"balance_after":58920,"source":{"system":"sec-edgar","filing":"0001209191-20-020279","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1679082/000120919120020279/doc4.xml","form_type":"4"}},{"id":3309162,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":112616,"kind":"person","name":"Sablich Kim","position":1,"cik":"0001758790","reported_name":"Sablich Kim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2020-01-16T17:28:28.000Z","date":"2020-01-15","kind":"sale","acquired":false,"shares":4840,"price":14.04,"value":67953.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares sold pursuant to a 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold at prices ranging from $14.00 to $14.12. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":59690,"source":{"system":"sec-edgar","filing":"0001209191-20-003741","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1679082/000120919120003741/doc4.xml","form_type":"4"}},{"id":3334927,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":112616,"kind":"person","name":"Sablich Kim","position":1,"cik":"0001758790","reported_name":"Sablich Kim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2019-12-19T16:25:21.000Z","date":"2019-12-18","kind":"sale","acquired":false,"shares":2585,"price":16.22,"value":41928.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I."}],"balance_after":64530,"source":{"system":"sec-edgar","filing":"0001209191-19-061300","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1679082/000120919119061300/doc4.xml","form_type":"4"}},{"id":3427825,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":112616,"kind":"person","name":"Sablich Kim","position":1,"cik":"0001758790","reported_name":"Sablich Kim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-08-27T16:59:36.000Z","date":"2019-08-26","kind":"grant","acquired":true,"shares":66130,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Each reported acquisition and disposition of an option for the like number of shares consisted of an amendment to an outstanding option, resulting in the deemed cancellation of the \"old\" option and grant of a replacement option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/4 of the common shares underlying this option vest on April 5, 2020, and 1/16 of the common shares underlying this option vest each quarter thereafter, provided the Reporting Person has provided continuous service to the Issuer or its affiliates on each such date."}],"balance_after":66130,"derivative":{"exercise_price":7.78,"expiration_date":"2029-04-04","underlying":"Common Shares","underlying_shares":66130},"source":{"system":"sec-edgar","filing":"0001209191-19-047548","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1679082/000120919119047548/doc4.xml","form_type":"4"}},{"id":3427824,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":112616,"kind":"person","name":"Sablich Kim","position":1,"cik":"0001758790","reported_name":"Sablich Kim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-08-27T16:59:36.000Z","date":"2019-08-26","kind":"disposition_to_issuer","acquired":false,"shares":66130,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Each reported acquisition and disposition of an option for the like number of shares consisted of an amendment to an outstanding option, resulting in the deemed cancellation of the \"old\" option and grant of a replacement option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/4 of the common shares underlying this option vest on April 5, 2020, and 1/16 of the common shares underlying this option vest each quarter thereafter, provided the Reporting Person has provided continuous service to the Issuer or its affiliates on each such date."}],"balance_after":0,"derivative":{"exercise_price":24.44,"expiration_date":"2029-04-04","underlying":"Common Shares","underlying_shares":66130},"source":{"system":"sec-edgar","filing":"0001209191-19-047548","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1679082/000120919119047548/doc4.xml","form_type":"4"}},{"id":3427823,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":112616,"kind":"person","name":"Sablich Kim","position":1,"cik":"0001758790","reported_name":"Sablich Kim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-08-27T16:59:36.000Z","date":"2019-08-26","kind":"grant","acquired":true,"shares":133500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Each reported acquisition and disposition of an option for the like number of shares consisted of an amendment to an outstanding option, resulting in the deemed cancellation of the \"old\" option and grant of a replacement option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/4 of the common shares underlying this option vest on December 17, 2019, and 1/16 of the common shares underlying this option vest each quarter thereafter, provided the Reporting Person has provided continuous service to the Issuer or its affiliates on each such date."}],"balance_after":133500,"derivative":{"exercise_price":7.78,"expiration_date":"2028-12-16","underlying":"Common Shares","underlying_shares":133500},"source":{"system":"sec-edgar","filing":"0001209191-19-047548","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1679082/000120919119047548/doc4.xml","form_type":"4"}},{"id":3427822,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":112616,"kind":"person","name":"Sablich Kim","position":1,"cik":"0001758790","reported_name":"Sablich Kim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-08-27T16:59:36.000Z","date":"2019-08-26","kind":"disposition_to_issuer","acquired":false,"shares":133500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Each reported acquisition and disposition of an option for the like number of shares consisted of an amendment to an outstanding option, resulting in the deemed cancellation of the \"old\" option and grant of a replacement option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/4 of the common shares underlying this option vest on December 17, 2019, and 1/16 of the common shares underlying this option vest each quarter thereafter, provided the Reporting Person has provided continuous service to the Issuer or its affiliates on each such date."}],"balance_after":0,"derivative":{"exercise_price":17.28,"expiration_date":"2028-12-16","underlying":"Common Shares","underlying_shares":133500},"source":{"system":"sec-edgar","filing":"0001209191-19-047548","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1679082/000120919119047548/doc4.xml","form_type":"4"}},{"id":3427821,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":112616,"kind":"person","name":"Sablich Kim","position":1,"cik":"0001758790","reported_name":"Sablich Kim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Shares","published_at":"2019-08-27T16:59:36.000Z","date":"2019-08-26","kind":"grant","acquired":true,"shares":37415,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Common Shares are to be acquired upon the vesting of certain Restricted Stock Units (\"RSUs\") granted to the Reporting Person. The RSUs shall vest as follows: (i) 1/3 of the total shares subject to the RSUs shall vest at the later occurrence of (a) the achievement of certain milestones and (b) the first anniversary of the grant date; and (ii) 2/3 of the total shares subject to the RSUs shall vest as follows: 1/8 vesting on the first anniversary of the grant date and 7/8 vesting in seven even installments each quarter thereafter, provided the Reporting Person has provided continuous service to the Issuer or its affiliates on each such date."}],"balance_after":67115,"source":{"system":"sec-edgar","filing":"0001209191-19-047548","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1679082/000120919119047548/doc4.xml","form_type":"4"}},{"id":3559055,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":112616,"kind":"person","name":"Sablich Kim","position":1,"cik":"0001758790","reported_name":"Sablich Kim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-04-09T18:23:41.000Z","date":"2019-04-05","kind":"grant","acquired":true,"shares":66130,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4 of the common shares underlying this option vest on April 5, 2020, and 1/16 of the common shares underlying this option vest at the end of each quarter thereafter, provided the Reporting Person has provided continuous service to the Issuer or its affiliates on each such date."}],"balance_after":66130,"derivative":{"exercise_price":24.44,"expiration_date":"2029-05-04","underlying":"Common Stock","underlying_shares":66130},"source":{"system":"sec-edgar","filing":"0001209191-19-024148","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1679082/000120919119024148/doc4.xml","form_type":"4"}},{"id":3726258,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":112616,"kind":"person","name":"Sablich Kim","position":1,"cik":"0001758790","reported_name":"Sablich Kim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-12-18T17:15:37.000Z","date":"2018-12-17","kind":"grant","acquired":true,"shares":133500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/4 of the common shares underlying this option vest on December 17, 2019, and 1/16 of the common shares underlying this option vest at the end of each quarter thereafter, provided the Reporting Person has provided continuous service to the Issuer or its affiliates on each such date."}],"balance_after":133500,"derivative":{"exercise_price":17.28,"expiration_date":"2028-12-16","underlying":"Common Shares","underlying_shares":133500},"source":{"system":"sec-edgar","filing":"0001209191-18-063255","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1679082/000120919118063255/doc4.xml","form_type":"4"}},{"id":3726257,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":112616,"kind":"person","name":"Sablich Kim","position":1,"cik":"0001758790","reported_name":"Sablich Kim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Shares","published_at":"2018-12-18T17:15:37.000Z","date":"2018-12-17","kind":"grant","acquired":true,"shares":29700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents common shares underlying a restricted stock unit award."},{"field":"shares","element":"transactionShares","label":"F2","text":"1/4 of the common shares underlying this restricted stock unit award vest on December 17, 2019, and 1/16 of the common shares underlying this restricted stock unit award vest at the end of each quarter thereafter, provided the Reporting Person has provided continuous service to the Issuer or its affiliates on each such date."}],"balance_after":29700,"source":{"system":"sec-edgar","filing":"0001209191-18-063255","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1679082/000120919118063255/doc4.xml","form_type":"4"}}]}